# [Epigenetics vs Genetics](/knowledge/molecular-biology/epigenetics-vs-genetics): Key Differences Explained

Genetics and epigenetics are two intertwined but fundamentally distinct layers of biological information. Genetics concerns the DNA sequence itself—the four-letter alphabet of A, T, G, and C that encodes proteins and structural RNAs. Epigenetics concerns the chemical modifications and chromatin-associated proteins that govern how that sequence is read, packaged, and expressed. The central distinction is that genetic changes alter the nucleotide sequence, whereas epigenetic changes alter gene activity without changing the sequence. This article dissects the mechanistic, heritable, and functional differences between these two domains, providing the conceptual framework you need for coursework and examinations.

## Introduction to Genetics and Epigenetics

The genome is often described as a blueprint, but that metaphor is incomplete. A blueprint implies a fixed, one-to-one correspondence between the plan and the building. In reality, every cell in your body contains the same DNA sequence, yet a neuron, a hepatocyte, and a lymphocyte are structurally and functionally distinct. The resolution to this paradox lies in the distinction between the genetic code and the epigenetic code.

### What is Genetics?

Genetics is the study of heredity and the variation of inherited characteristics. At the molecular level, it is the study of DNA sequence: the order of nucleotides along a chromosome. Genetic variation arises from mutations—permanent changes in the DNA sequence that can be point mutations (single nucleotide substitutions), insertions, deletions, duplications, or chromosomal rearrangements. These changes are the raw material for evolution and are responsible for Mendelian traits such as sickle cell anemia (a single A to T transversion in the β-globin gene, *HBB*, at codon 6) or Huntington's disease (an expansion of CAG repeats in *HTT*).

Genetic information is stored in the linear sequence of bases and is faithfully copied during DNA replication. The stability of the genome is maintained by DNA polymerases with proofreading activity and by mismatch repair systems that correct replication errors. The mutation rate in human nuclear DNA is approximately 1.1 × 10⁻⁸ per base pair per generation, meaning each human newborn carries roughly 70 new point mutations relative to their parents. This low but nonzero error rate is the foundation of genetic diversity.

### What is Epigenetics?

Epigenetics is the study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence. The term, coined by Conrad Waddington in 1942, originally described the "causal interactions between genes and their products which bring the phenotype into being." Today, it is defined molecularly: epigenetic marks are chemical modifications to DNA and histone proteins, along with non-coding RNAs, that influence chromatin structure and gene accessibility.

The key word is *heritable*. Epigenetic marks must be passed on during cell division to qualify as epigenetic, as opposed to merely transient transcriptional regulation. This heritability is what allows a liver cell to divide and produce daughter cells that are also liver cells, despite all cells sharing the same genome. The epigenome—the complete set of epigenetic modifications in a cell—is what differentiates cell types and maintains cellular identity.

The fundamental difference is that genetics asks *what sequence is present*, while epigenetics asks *how is that sequence packaged and expressed*. For a deeper conceptual overview, see [Epigenetics Explained](/knowledge/molecular-biology/epigenetics-explained).

## Core Differences in Mechanism

The mechanistic divide between genetics and epigenetics is stark. Genetic changes are alterations to the chemical structure of DNA. Epigenetic changes are alterations to the proteins and chemical groups that associate with DNA, or to the RNA molecules that regulate its output.

### DNA Sequence vs. Chromatin Structure

In the nucleus, DNA is not naked. It is wrapped around histone octamers—each composed of two copies of H2A, H2B, H3, and H4—to form nucleosomes, which are further compacted into higher-order chromatin fibers. This packaging is dynamic. Euchromatin is loosely packed and transcriptionally active; heterochromatin is densely packed and transcriptionally silent.

Genetic mutations change the DNA sequence itself. A mutation in a promoter can abolish transcription factor binding; a mutation in a coding exon can change an amino acid or introduce a premature stop codon. These are *cis*-acting changes to the template.

Epigenetic modifications change how the DNA is packaged without altering its sequence. DNA methylation involves the covalent addition of a methyl group to the 5' carbon of cytosine residues, typically in CpG dinucleotides, catalyzed by DNA methyltransferases (DNMTs). Methylation in promoter regions generally represses transcription by recruiting methyl-CpG-binding domain proteins and preventing transcription factor access.

Histone modifications are post-translational modifications to the N-terminal tails of histones. Acetylation of lysine residues (e.g., H3K27ac, H3K9ac) neutralizes the positive charge of the histone tail, weakening its interaction with negatively charged DNA and opening the chromatin. Methylation of lysine or arginine residues can be activating or repressing depending on the specific residue and degree of methylation (e.g., H3K4me3 is activating; H3K27me3 is repressive).

The critical point is that a genetic mutation is a change in the *information content* of the DNA. An [epigenetic modification](/knowledge/molecular-biology/epigenetic-modification) is a change in the *accessibility* of that information. A gene can be intact and mutation-free but silenced by promoter methylation or repressive histone marks; conversely, a gene can carry a mutation but be expressed if the chromatin is open.

### Reversible vs. Irreversible Changes

Genetic mutations are essentially irreversible within an organism's lifetime. While [DNA repair mechanisms](/knowledge/molecular-biology/dna-repair) can correct damage, an established mutation in a germline or somatic cell is permanent and is copied faithfully during subsequent rounds of replication. There is no enzymatic machinery that "reverts" a mutation back to the wild-type sequence at a meaningful frequency.

Epigenetic modifications are reversible by design. DNA methylation can be actively removed by ten-eleven translocation (TET) enzymes, which oxidize 5-methylcytosine to 5-hydroxymethylcytosine and further derivatives, ultimately leading to base excision repair and replacement with unmodified cytosine. Histone modifications are removed by histone deacetylases (HDACs) and histone demethylases (e.g., LSD1, JmjC-domain proteins). This reversibility is essential for cellular plasticity—the ability of cells to respond to signals, differentiate, and, in some contexts, dedifferentiate.

The reversibility of epigenetic marks is the basis for epigenetic therapies. The nucleoside analog 5-azacytidine (Vidaza) and 5-aza-2'-deoxycytidine (decitabine, Dacogen) are incorporated into DNA during replication and trap DNMTs, leading to their degradation and passive demethylation. These drugs are approved for myelodysplastic syndromes and acute myeloid leukemia. HDAC inhibitors such as vorinostat (SAHA) and romidepsin are approved for cutaneous T-cell lymphoma. No equivalent "mutation reversal" drugs exist.

## Heritability: Genetic vs. [Epigenetic Inheritance](/knowledge/molecular-biology/epigenetic-inheritance)

Both genetic and epigenetic information are heritable, but the mechanisms and fidelity differ substantially.

### Mitotic Inheritance

Genetic information is inherited with near-perfect fidelity during mitosis. DNA replication is semiconservative, with each daughter strand synthesized complementary to the parental strand. The error rate, even without repair, is approximately 10⁻⁴ to 10⁻⁵, and with proofreading and mismatch repair, it drops to 10⁻⁹ to 10⁻¹⁰.

Epigenetic marks are also inherited through mitosis, but the mechanism is less direct. DNA methylation is maintained by DNMT1, which recognizes hemimethylated CpG sites—where the parental strand is methylated but the newly synthesized daughter strand is not—and methylates the daughter strand. This "maintenance methylation" ensures that methylation patterns are copied with approximately 95–98% fidelity per cell division.

Histone modifications are inherited through a more stochastic process. Parental histones are distributed to both daughter strands during replication, and the new histones deposited on the daughter strands are modified by reader-writer complexes that copy the modification pattern from adjacent parental histones. This process is less faithful than DNA methylation maintenance, contributing to the plasticity of histone marks.

### Transgenerational [Epigenetic Inheritance](/knowledge/molecular-biology/epigenetic-inheritance)

Genetic mutations in the germline are passed to offspring with a clear Mendelian inheritance pattern. Epigenetic inheritance across generations is more controversial and mechanistically complex.

For epigenetic marks to be inherited transgenerationally, they must survive two rounds of epigenetic reprogramming: one in the developing germ cells and one in the early embryo. In mammals, the zygote undergoes genome-wide demethylation shortly after fertilization, and the primordial germ cells undergo a second wave of demethylation during development. Most epigenetic marks are erased during these windows.

However, some loci escape reprogramming. Imprinted genes maintain their parent-of-origin-specific methylation through both waves. Additionally, some evidence suggests that environmental exposures can induce epigenetic changes in germ cells that persist into subsequent generations. For example, exposure of pregnant female mice to the endocrine disruptor vinclozolin during a specific window of gonadal development leads to altered DNA methylation patterns in the sperm of F1 males, which are transmitted to F2 and F3 generations. The mechanistic basis for this transmission is debated, but it likely involves the retention of some histone modifications in sperm and the action of small non-coding RNAs.

It is critical to distinguish between *intergenerational* and *transgenerational* inheritance. If a pregnant female (F0) is exposed to a toxin, the F1 fetus and its F2 germ cells are directly exposed. Effects seen in F1 or F2 could be due to direct exposure, not epigenetic inheritance. True transgenerational inheritance requires effects to persist in F3 (for a paternal exposure) or F4 (for a maternal exposure). For further reading on this topic, see [Epigenetics Inherited](/knowledge/molecular-biology/epigenetics-inherited).

## Types of Epigenetic Modifications

The molecular machinery of epigenetics comprises three main classes of modifications: DNA methylation, histone modifications, and non-coding RNAs. Each operates through distinct mechanisms and has distinct effects on gene expression.

### DNA Methylation

DNA methylation is the best-characterized epigenetic mark. It involves the covalent addition of a methyl group to the 5' position of cytosine, creating 5-methylcytosine (5mC). This reaction is catalyzed by DNA methyltransferases:

- **DNMT3A and DNMT3B** establish *de novo* methylation patterns during development.
- **DNMT1** maintains methylation during replication.

The reaction uses S-adenosylmethionine (SAM) as the methyl donor. In mammals, methylation occurs almost exclusively at CpG dinucleotides. CpG islands—regions of high CpG density—are found in approximately 60–70% of human gene promoters. Most CpG islands are unmethylated, allowing gene expression. Methylation of CpG islands in promoters is associated with stable transcriptional repression.

Methylation represses transcription through two mechanisms. First, methylated cytosines physically impede the binding of [transcription factors](/knowledge/molecular-biology/transcription-factor). Second, methyl-CpG-binding domain (MBD) proteins, such as MeCP2 and MBD1-3, bind to methylated DNA and recruit co-repressor complexes containing HDACs and histone methyltransferases, leading to chromatin compaction.

Approximately 70–80% of CpG dinucleotides in the human genome are methylated, but most are in repetitive elements, transposons, and gene bodies rather than promoters. Methylation of transposons and repetitive elements is a defense mechanism that silences these parasitic genetic elements.

### Histone Acetylation and Methylation

Histone modifications are diverse. The N-terminal tails of histones protrude from the nucleosome and are subject to acetylation, methylation, phosphorylation, ubiquitination, SUMOylation, and ADP-ribosylation. The two most studied are acetylation and methylation.

**Histone acetylation** is catalyzed by histone acetyltransferases (HATs), such as p300/CBP, GCN5, and PCAF. These enzymes transfer an acetyl group from acetyl-CoA to the ε-amino group of lysine residues. Acetylation neutralizes the positive charge on lysine, weakening electrostatic interactions between the histone tail and the negatively charged DNA backbone. This promotes an open chromatin conformation and facilitates transcription factor access. Acetylation is removed by histone deacetylases (HDACs), which restore the positive charge and promote chromatin compaction.

**Histone methylation** is catalyzed by histone methyltransferases (HMTs) and removed by histone demethylases. Unlike acetylation, methylation does not change the charge of the histone tail. Instead, it creates binding sites for effector proteins. For example:

- **H3K4me3** (trimethylation of lysine 4 on histone H3) is enriched at active promoters and is bound by the TFIID complex, promoting [transcription initiation](/knowledge/molecular-biology/transcription-initiation).
- **H3K36me3** is enriched in gene bodies of actively transcribed genes and is deposited by SETD2 during transcriptional elongation.
- **H3K27me3** is deposited by the Polycomb repressive complex 2 (PRC2) and is associated with facultative heterochromatin and gene silencing.
- **H3K9me3** is deposited by SUV39H1/2 and is a hallmark of constitutive heterochromatin, particularly at centromeres and telomeres.

The "histone code" hypothesis posits that combinations of histone modifications act as a code read by effector proteins to determine chromatin state and gene expression. While the code metaphor is debated, the functional consequences of specific modifications are well established.

### Non-coding RNAs

Non-coding RNAs (ncRNAs) are RNA molecules that do not encode proteins but regulate gene expression. They are often considered epigenetic because they can heritably alter gene expression and chromatin state.

**MicroRNAs (miRNAs)** are ~22-nucleotide RNAs that bind to complementary sequences in the 3' untranslated regions (UTRs) of messenger RNAs, leading to mRNA degradation or translational repression. There are over 2,000 human miRNAs, and each can target hundreds of mRNAs.

**Long non-coding RNAs (lncRNAs)** are >200 nucleotides and regulate gene expression through diverse mechanisms. The classic example is **XIST**, which is transcribed from the X chromosome and coats the inactive X chromosome in cis, recruiting the Polycomb complex PRC2 to deposit H3K27me3 and silence the chromosome. Another example is **HOTAIR**, transcribed from the HOXC locus, which recruits PRC2 to the HOXD locus in trans.

**Small interfering RNAs (siRNAs)** and **Piwi-interacting RNAs (piRNAs)** also contribute to epigenetic regulation, particularly in the silencing of transposons in the germline.

## Methods to Study Epigenetics vs. Genetics

The tools used to study genetics and epigenetics differ because the questions differ. Geneticists ask "what is the sequence?" Epigeneticists ask "what is the modification state, chromatin accessibility, or expression level?"

### Genomic Sequencing

Genetic analysis relies on DNA sequencing. **Sanger sequencing** is the gold standard for targeted sequencing of specific loci. **Next-generation sequencing (NGS)** platforms, such as Illumina's sequencing-by-synthesis, allow whole-genome sequencing (WGS) and whole-exome sequencing (WES). These methods identify single nucleotide variants (SNVs), insertions, deletions, and structural variants.

For genetic analysis, DNA is extracted, fragmented, adapter-ligated, and amplified. The sequencing reaction involves cycles of nucleotide incorporation, imaging, and cleavage. Typical Illumina runs produce 150-base pair paired-end reads, with depths of 30× for WGS and 100× or more for targeted panels.

### Epigenomic Profiling

Epigenetic analysis requires methods that preserve and detect modifications.

**Bisulfite sequencing** is the gold standard for DNA methylation analysis. Treatment of DNA with sodium bisulfite converts unmethylated cytosines to uracil, while methylated cytosines are protected. After PCR amplification, uracils are read as thymines. Comparing bisulfite-treated and untreated sequences reveals the methylation status of each cytosine. Whole-genome bisulfite sequencing (WGBS) provides single-base resolution genome-wide, but at high cost. Reduced representation bisulfite sequencing (RRBS) enriches for CpG-rich regions using restriction enzymes such as *MspI* (which cuts CCGG sites) followed by size selection.

**Chromatin immunoprecipitation followed by sequencing (ChIP-seq)** identifies the genomic locations of histone modifications or DNA-binding proteins. Cells are cross-linked with 1% formaldehyde for 10 minutes at room temperature, quenched with glycine, and lysed. Chromatin is sheared by sonication to fragments of 200–600 base pairs. An antibody specific to the modification of interest (e.g., anti-H3K27ac) is used to immunoprecipitate the protein-DNA complexes. After reversing cross-links and purifying DNA, the enriched fragments are sequenced. ChIP-seq requires 10⁶–10⁷ cells and high-quality antibodies; the ENCODE project has established standards including peak calling with MACS2 and IDR analysis for reproducibility.

**ATAC-seq (Assay for Transposase-Accessible Chromatin)** maps open chromatin regions. The hyperactive Tn5 transposase simultaneously fragments and tags accessible DNA with sequencing adapters. The reaction is performed at 37°C for 30 minutes in a buffer containing 10 mM Tris-HCl (pH 7.5), 5 mM MgCl₂, and 10% dimethylformamide. Accessible regions—promoters, enhancers, and insulators—are identified as peaks. ATAC-seq requires only 500–50,000 cells, making it ideal for rare cell populations.

**Hi-C** and its derivatives (e.g., HiChIP, PLAC-seq) map three-dimensional chromatin architecture. DNA is cross-linked, digested with a restriction enzyme such as *HindIII*, and the ends are filled in with biotinylated nucleotides. The fragments are ligated, and biotinylated junctions are purified and sequenced. This reveals which genomic regions are in physical proximity in the nucleus.

## Examples and Evidence of Epigenetic Phenomena

Several classic phenomena illustrate the functional consequences of epigenetic regulation and its distinction from genetic change.

### X-Chromosome Inactivation

Female mammals have two X chromosomes; males have one X and one Y. To equalize X-linked gene dosage, one X chromosome in each female cell is transcriptionally silenced. This process, called X-inactivation or Lyonization, is random and occurs early in embryonic development (around the blastocyst stage, day 5–6 in humans).

The inactive X chromosome (Xi) is characterized by:

- **XIST RNA** coating the chromosome in cis
- **H3K27me3** enrichment
- **DNA methylation** of CpG islands in promoters
- **Late replication** in S phase
- Condensation into a **Barr body**

The choice of which X is inactivated is stochastic, but once made, it is clonally inherited. A female heterozygous for an X-linked gene (e.g., glucose-6-phosphate dehydrogenase, *G6PD*) will have a mosaic pattern: some cells express the maternal allele, others the paternal allele. This is a purely epigenetic phenomenon—the DNA sequence of both X chromosomes is identical, but their expression states differ.

### Genomic Imprinting

Genomic imprinting is an epigenetic phenomenon where a subset of genes is expressed only from one parental allele. Approximately 100–200 imprinted genes exist in humans. The imprint is established in the germline through DNA methylation at imprinting control regions (ICRs).

The classic example is **IGF2/H19** on chromosome 11p15.5. The *IGF2* gene encodes insulin-like growth factor 2 and is expressed only from the paternal allele. The *H19* gene encodes a lncRNA and is expressed only from the maternal allele. The regulation involves a differentially methylated region (DMR) upstream of *H19*. On the maternal chromosome, the DMR is unmethylated, allowing the insulator protein CTCF to bind and block an enhancer from activating *IGF2*, while promoting *H19* expression. On the paternal chromosome, the DMR is methylated, preventing CTCF binding and allowing the enhancer to activate *IGF2*.

Loss of imprinting (LOI) at this locus causes Beckwith-Wiedemann syndrome, characterized by overgrowth and predisposition to Wilms tumor. The molecular defect is often loss of methylation at the maternal ICR, leading to biallelic *IGF2* expression.

### Cellular Differentiation

Cellular differentiation is the process by which pluripotent stem cells become specialized cell types. This process is driven by epigenetic changes that stably silence pluripotency genes and activate lineage-specific genes.

In embryonic stem cells (ESCs), the promoters of developmental regulator genes are "poised"—they carry both H3K4me3 (activating) and H3K27me3 (repressive) marks. These bivalent domains keep genes silent but ready for activation. Upon differentiation, lineage-specific genes lose H3K27me3 and gain additional H3K4me3, becoming fully active, while genes for alternative lineages lose H3K4me3 and gain H3K27me3, becoming stably repressed.

The transcription factors OCT4, SOX2, and NANOG maintain pluripotency by binding to enhancers and recruiting chromatin remodelers. When ESCs differentiate, these factors are downregulated, and their target enhancers become methylated and closed. This is why induced pluripotent stem cell (iPSC) reprogramming—introducing OCT4, SOX2, KLF4, and c-MYC—requires the erasure of somatic epigenetic marks and re-establishment of the pluripotent epigenome. The process is inefficient (typically 0.01–1% of cells) precisely because epigenetic reprogramming is difficult.

## Environmental Influence and Plasticity

A defining feature of epigenetics is its responsiveness to environmental signals. Unlike genetic mutations, which arise randomly or from DNA damage, epigenetic marks can be actively deposited or removed in response to external cues.

### Nutrition and Epigenetics

Dietary components can influence epigenetic marks by altering the availability of methyl donors or by directly inhibiting epigenetic enzymes.

**Folate, vitamin B12, and choline** are sources of one-carbon units for the synthesis of SAM, the universal methyl donor. Deficiencies in these nutrients reduce SAM levels and can lead to global DNA hypomethylation. In the agouti mouse model, dietary methyl donor supplementation of pregnant mothers shifts the coat color of offspring from yellow (agouti gene expressed due to hypomethylation of an upstream retrotransposon) to brown (gene silenced by hypermethylation).

**Polyphenols** such as curcumin (from turmeric), epigallocatechin-3-gallate (EGCG, from green tea), and resveratrol (from grapes) can inhibit DNMTs and HDACs. EGCG at concentrations of 5–50 μM inhibits DNMT1 activity in vitro. These compounds are being investigated as chemopreventive agents.

### Stress and Epigenetic Marks

Early-life stress can induce lasting epigenetic changes. In rats, high levels of maternal licking and grooming in the first week of life lead to demethylation of the glucocorticoid receptor (*Nr3c1*) promoter in the hippocampus, increasing receptor expression and improving stress resilience. Offspring of low-licking mothers have hypermethylation at this promoter and heightened stress responses. Cross-fostering experiments demonstrate that this effect is environmental, not genetic.

In humans, studies of childhood abuse have found increased methylation of the *NR3C1* promoter in hippocampal tissue of suicide completers compared to controls. The *FKBP5* gene, which encodes a co-chaperone of the glucocorticoid receptor, shows demethylation at glucocorticoid response elements in individuals with a history of childhood trauma, leading to increased *FKBP5* expression and altered stress signaling. These findings connect early-life environment to long-term epigenetic changes, with implications for psychiatric risk. For a broader discussion of these phenomena, see [Epigenetics Psychology](/knowledge/molecular-biology/epigenetics-psychology).

## Common Pitfalls and Misconceptions

Students frequently misunderstand the relationship between genetics and epigenetics. The following points address the most common errors.

### Epigenetics is Not Lamarckian

Jean-Baptiste Lamarck proposed that traits acquired during an organism's lifetime could be inherited by offspring. Epigenetics is sometimes incorrectly invoked as evidence for Lamarckian inheritance. This is an oversimplification.

Epigenetic changes can be influenced by the environment, and some can be transmitted to offspring. However, the vast majority of epigenetic marks are reset during gametogenesis and embryogenesis. Transgenerational epigenetic inheritance is rare, mechanistically debated, and does not approach the stability or information content of genetic inheritance. Moreover, epigenetic changes do not alter the DNA sequence, so they cannot direct the evolution of new genetic information.

### Epigenetics Does Not Change the Genetic Code

A common misconception is that epigenetic modifications mutate or alter the DNA sequence. They do not. DNA methylation adds a methyl group to a cytosine base; the base remains cytosine. Histone modifications alter proteins, not DNA. Non-coding RNAs regulate gene expression without changing the genome.

This distinction has practical consequences. Epigenetic changes are reversible, while genetic mutations are not. Epigenetic changes can be targeted by drugs; mutations cannot. And epigenetic changes do not change the amino acid sequence of proteins, whereas mutations in coding regions can.

### Epigenetic Marks are Not Always Stable

Students often assume that epigenetic marks are permanent. In reality, epigenetic states exist on a spectrum of stability. Some marks, such as DNA methylation at imprinted loci, are highly stable and maintained through development. Others, such as histone acetylation, turn over rapidly—the half-life of histone acetylation is on the order of minutes to hours. The dynamic nature of epigenetic marks is essential for cellular responses to signals.

### Correlation is Not Causation

Many studies report associations between epigenetic marks and phenotypes or exposures. However, demonstrating that an epigenetic change *causes* a phenotype requires functional experiments. For example, showing that a promoter is hypermethylated in cancer cells does not prove that methylation caused the silencing; the methylation could be a consequence of the silencing. Causal evidence requires experiments such as targeted demethylation with dCas9-TET1 fusions or reactivation with DNMT inhibitors.

## Summary and Practical Implications

The distinction between genetics and epigenetics is fundamental to understanding gene regulation, development, and disease.

### Key Takeaways

- **Genetics** is the study of DNA sequence and its variation; **epigenetics** is the study of heritable changes in gene expression that do not involve sequence changes.
- **Genetic changes** are permanent, irreversible alterations to the nucleotide sequence; **epigenetic changes** are reversible modifications to DNA (methylation), histones (acetylation, methylation), and RNA.
- **Epigenetic marks** are heritable through mitosis via maintenance mechanisms (DNMT1 for DNA methylation) and can, in rare cases, be transmitted transgenerationally.
- **The same DNA sequence** can produce different phenotypes depending on its epigenetic state, as exemplified by X-inactivation, genomic imprinting, and cellular differentiation.
- **Epigenetic marks** are responsive to environmental cues including nutrition, stress, and toxins, whereas genetic mutations arise from replication errors or DNA damage.
- **Epigenetic therapies** (DNMT inhibitors, HDAC inhibitors) are approved for cancer treatment, highlighting the clinical relevance of epigenetic reversibility.
- **The epigenome** is cell-type-specific, whereas the genome is identical across somatic cells of an individual.

### Applications in Medicine and Research

Understanding epigenetics has transformed medicine. Cancer is now recognized as both a genetic and epigenetic disease. [Tumor suppressor genes](/knowledge/molecular-biology/tumor-suppressor-gene) can be silenced by promoter hypermethylation (e.g., *MLH1* in colorectal cancer, *CDKN2A* in many cancers), and oncogenes can be activated by hypomethylation. Epigenetic marks are used as biomarkers: the methylation status of *MGMT* predicts response to temozolomide in glioblastoma, and the methylation of *SEPT9* is a blood-based screening test for colorectal cancer.

In biotechnology, epigenetic engineering using CRISPR-dCas9 fused to epigenetic editors (e.g., dCas9-DNMT3A for methylation, dCas9-p300 for acetylation) allows targeted manipulation of gene expression without altering the DNA sequence. This technology has potential for treating diseases caused by aberrant gene silencing, such as Friedreich's ataxia, where the *FXN* gene is silenced by heterochromatin expansion.

In evolutionary biology, epigenetics provides a mechanism for phenotypic plasticity—the ability of a single genotype to produce different phenotypes in different environments. This plasticity may facilitate adaptation to new environments before genetic mutations arise.

The relationship between genetics and epigenetics is not oppositional but complementary. The genome provides the information; the epigenome determines how that information is used. For a concise comparison, see [Epigenetics vs Genetics](/knowledge/molecular-biology/epigenetics-vs-genetics). For a definition-focused overview, see [Epigenetics Definition](/knowledge/molecular-biology/epigenetics-definition). The importance of this field for human health is detailed in [Epigenetics in Humans](/knowledge/molecular-biology/epigenetics-in-humans) and [Epigenetics Important](/knowledge/molecular-biology/epigenetics-important).

## Frequently Asked Questions

### Why is epigenetics different from genetics?

Genetics concerns the DNA sequence—the order of nucleotides that encodes genes. Epigenetics concerns chemical modifications to DNA and histones, and regulatory RNAs, that alter gene expression without changing the sequence. A genetic change is a mutation that permanently alters the sequence; an epigenetic change is a reversible modification that alters gene accessibility. For a direct comparison, see [Epigenetics Differ from Genetics](/knowledge/molecular-biology/epigenetics-differ-from-genetics).

### Can epigenetic changes be inherited?

Yes, but with important caveats. Epigenetic marks are faithfully inherited during mitosis through maintenance mechanisms: DNMT1 copies DNA methylation patterns, and histone-modifying enzymes copy histone marks. This mitotic inheritance is how cell identity is maintained. Transgenerational inheritance (through meiosis to offspring) occurs but is rare, as most marks are erased during germline and embryonic reprogramming. Imprinted genes are the clearest example of transgenerational epigenetic inheritance.

### Do epigenetic changes alter the DNA sequence?

No. Epigenetic modifications are additions to, or changes in association with, the DNA, but the nucleotide sequence itself is unchanged. DNA methylation adds a methyl group to cytosine; histone modifications alter histone proteins; non-coding RNAs regulate expression. The sequence of A, T, G, and C remains identical. This is why epigenetic changes are reversible and why they do not change the amino acid sequence of proteins.

### Are epigenetic changes reversible?

Yes. Unlike genetic mutations, epigenetic modifications are enzymatically reversible. DNA methylation is removed by TET enzymes. Histone acetylation is removed by HDACs. Histone methylation is removed by histone demethylases. This reversibility is exploited clinically: DNMT inhibitors (5-azacytidine, decitabine) and HDAC inhibitors (vorinostat, romidepsin) are approved cancer drugs that reactivate silenced genes.

### What are examples of epigenetic differences?

Classic examples include: X-chromosome inactivation, where one X chromosome in female cells is silenced by XIST RNA and repressive histone marks; genomic imprinting, where genes like *IGF2* are expressed only from one parental allele due to differential DNA methylation; and cellular differentiation, where pluripotent stem cells become specialized cells through the establishment of cell-type-specific chromatin states. Monozygotic twins are genetically identical but show epigenetic differences that increase with age and environmental exposure.

### How do scientists study epigenetics?

Common methods include: bisulfite sequencing for DNA methylation (converts unmethylated cytosines to uracil); ChIP-seq for histone modifications and transcription factor binding (immunoprecipitates cross-linked protein-DNA complexes); ATAC-seq for chromatin accessibility (uses Tn5 transposase to tag open chromatin); and Hi-C for three-dimensional chromatin architecture. These methods are typically combined with RNA-seq to link epigenetic states to gene expression.

### Can the environment affect epigenetics?

Yes. Nutrition, stress, toxins, and other environmental factors can alter epigenetic marks. Dietary methyl donors (folate, vitamin B12, choline) affect SAM levels and DNA methylation. Early-life stress can alter methylation of the glucocorticoid receptor promoter. Toxins such as bisphenol A and heavy metals can disrupt epigenetic regulation. These environmentally induced changes can be stable within an individual and, in some cases, may be transmitted to offspring.

## Further Reading

- Ntontsi P et al. *Genetics and Epigenetics in Asthma*. International journal of molecular sciences. 2021. [PubMed 33673725](https://doi.org/10.3390/ijms22052412)
- Vatier C, Christin-Maitre S. *Epigenetic/circadian clocks and PCOS*. Human reproduction (Oxford, England). 2024. [PubMed 38600622](https://doi.org/10.1093/humrep/deae066)
- Koninckx PR et al. *Pathogenesis of endometriosis: the genetic/epigenetic theory*. Fertility and sterility. 2019. [PubMed 30527836](https://doi.org/10.1016/j.fertnstert.2018.10.013)
- Arnau-Soler A et al. *Food Allergy Genetics and Epigenetics: A Review of Genome-Wide Association Studies*. Allergy. 2025. [PubMed 39698764](https://doi.org/10.1111/all.16429)
- Cuevas-Sierra A et al. *Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications*. Advances in nutrition (Bethesda, Md.). 2019. [PubMed 30721960](https://doi.org/10.1093/advances/nmy078)
- D'Agnelli S et al. *Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers*. Molecular pain. 2019. [PubMed 30486733](https://doi.org/10.1177/1744806918819944)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)